Search Results for "Tingkatan Satu Sejarah Nota"

13:51 EDT 25th June 2016 | BioPortfolio

Matching Channels


Matching News

ValiRx raises £500,000 to progess cancer trial

ValiRx (LON:VAL) has raised £503,000 gross through a placing at 12p per to fund its drug development pipeline. ValiRx has one drug, VAL201, going through  phase I/II trials, and has made an ap...

ValiRx PLC targets US institutions with new appointment

ValiRx Plc (LON:VAL) has appointed a specialist investor relations firm to build its recognition among academic, clinical, and business leaders in the US.  Burns McClellan has already carried o...

ValiRx PLC to present at leading US cancer conference

Shares in ValiRx PLC (LON:VAL) rose 2% after the life sciences specialist said it would be presenting research data at a leading oncology get-together in the US next month. The American Association ...

ValiRx: Bioscience Innovation

In this interview, filmed during BioEurope 2008 in Madrid, Fintan Walton speaks with Satu Vainikka, CEO of ValiRx, an AIM listed biopharmaceutical company based in the UK. Focusing on epigenetics, Val...

Janssen Announces the Initiation of Two Studies Evaluating Daratumumab (DARZALEX®) and Atezolizumab in Multiple Myeloma and Solid Tumor

RARITAN, N.J., March 21, 2016 /PRNewswire/ -- Janssen Research & Development, LLC announced today it has entered into a clinical trial collaboration agreement with Genentech, a member of the ...

Global Bone Graft Substitute Industry

LONDON, May 26, 2016 /PRNewswire/ -- This report analyzes the worldwide markets for Bone Graft Substitutes in US$ Million. The US market is further analyzed by the following Segments: Demineralized Bo...

Matching PubMed Articles

Prognostic Value of 68Ga-NOTA-RGD PET/CT for Predicting Disease-Free Survival for Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy and Surgery: A Comparison Study With Dynamic Contrast Enhanced MRI.

We performed pretreatment angiogenesis imaging (Ga-NOTA-arginyl-glycyl-aspartic acid [RGD] PET/CT) to compare its prognostic value to dynamic contrast-enhanced (DCE) MRI in breast cancer patients.

Development of a Novel PET Tracer 18FAlF-NOTA-C6 Targeting MMP2 for Tumor Imaging.

The overexpression of gelatinases, that is, matrix metalloproteinase MMP2 and MMP9, has been associated with tumor progression, invasion, and metastasis. To image MMP2 in tumors, we developed a novel ...

Development and characterization of an αvβ6-specific diabody and a disulfide-stabilized αvβ6-specific cys-diabody.

This work describes the development and characterization of two antibody fragments that specifically target the αvβ6 integrin, a non-covalent diabody and a disulfide-stabilized cys-diabody. The diab...

Synthesis and in vivo PET Imaging of Hyaluronan Conjugates of Oligonucleotides.

Synthesis for 68Ga-labelled 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA)-chelated oligonucleotide hyaluronan (HA) tetra- and hexasaccharide conjugates is described. A solid-supported technique ...

The feasibility of 18F-AlF-NOTA-PRGD2 PET/CT for monitoring early response of Endostar antiangiogenic therapy in human nasopharyngeal carcinoma xenograft model compared with 18F-FDG.

Radiolabeled arginine-glycine-aspartic acid (RGD) peptides have been developed for PET imaging of integrin avβ3 in the tumor vasculature, leading to great potential for noninvasively evaluating tumor...

Search Whole site using Google

Quick Search
Advertisement Advertisement